BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12731447)

  • 1. [Neuroendocrine renal carcinoma. Presentation of a case].
    Piedra Lara JD; Tejido Sánchez A; García de la Torre JP; Capitán Manjón C; Cruceyra Betriu G; Leiva Galvis O
    Arch Esp Urol; 2003 Mar; 56(2):178-81. PubMed ID: 12731447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age at diagnosis is an independent predictor of small renal cell carcinoma recurrence-free survival.
    Jeong IG; Yoo CH; Song K; Park J; Cho YM; Song C; Hong JH; Ahn H; Kim CS
    J Urol; 2009 Aug; 182(2):445-50. PubMed ID: 19524959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas.
    Klatte T; Patard JJ; de Martino M; Bensalah K; Verhoest G; de la Taille A; Abbou CC; Allhoff EP; Carrieri G; Riggs SB; Kabbinavar FF; Belldegrun AS; Pantuck AJ
    J Urol; 2008 May; 179(5):1719-26. PubMed ID: 18343437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum immunosuppressive acidic protein doubling time as a prognostic factor for recurrent renal cell carcinoma after nephrectomy.
    Araki K; Igarashi T; Tobe T; Mizoguchi K; Suzuki H; Furuya Y; Ichikawa T; Nakatsu HO; Ito H
    Urology; 2006 Dec; 68(6):1178-82. PubMed ID: 17141843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resection of local recurrence of renal cell carcinoma in a hemodialysis patient 6 years after radical nephrectomy.
    Irie K; Ishizuka O; Yokoyama H; Kinebuchi Y; Satoh T; Nishizawa O
    Int J Urol; 2004 Jul; 11(7):550-2. PubMed ID: 15242367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic metastasis from renal carcinoma managed by Whipple resection. A case report and literature review of metastatic pattern, surgical management and outcome.
    Machado NO; Chopra P
    JOP; 2009 Jul; 10(4):413-8. PubMed ID: 19581746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solitary metastasis of renal cell carcinoma to the parotid gland 10 years after radical nephrectomy.
    Göğüş C; Kiliç O; Tulunay O; Tulunay O; Bedük Y
    Int J Urol; 2004 Oct; 11(10):894-6. PubMed ID: 15479296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.
    Margulis V; McDonald M; Tamboli P; Swanson DA; Wood CG
    J Urol; 2009 May; 181(5):2044-51. PubMed ID: 19286220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes following partial nephrectomy by tumor size.
    Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
    J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single center preliminary experience with hand-assisted laparoscopic resection of isolated renal cell carcinoma fossa recurrences.
    Bandi G; Wen CC; Moon TD; Nakada SY
    Urology; 2008 Mar; 71(3):495-9; discussion 499-500. PubMed ID: 18342195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combined small cell and transitional cell carcinoma of renal pelvis: a case report].
    Kuromatsu I; Hayashi N; Yanagawa M; Tochigi H; Kawamura J
    Hinyokika Kiyo; 1995 Jan; 41(1):47-50. PubMed ID: 7900568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microvascular tumor invasion, tumor size and Fuhrman grade: a pathological triad for prognostic evaluation of renal cell carcinoma.
    Dall'Oglio MF; Ribeiro-Filho LA; Antunes AA; Crippa A; Nesrallah L; Gonçalves PD; Leite KR; Srougi M
    J Urol; 2007 Aug; 178(2):425-8; discussion 428. PubMed ID: 17561167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence.
    Eggener SE; Yossepowitch O; Pettus JA; Snyder ME; Motzer RJ; Russo P
    J Clin Oncol; 2006 Jul; 24(19):3101-6. PubMed ID: 16809736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes.
    Parekh DJ; Cookson MS; Chapman W; Harrell F; Wells N; Chang SS; Smith JA
    J Urol; 2005 Jun; 173(6):1897-902. PubMed ID: 15879771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elective nephron sparing surgery for renal cell carcinoma larger than 4 cm.
    Pahernik S; Roos F; Röhrig B; Wiesner C; Thüroff JW
    J Urol; 2008 Jan; 179(1):71-4; discussion 74. PubMed ID: 17997423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephron-sparing surgery for renal cell carcinoma in the solitary kidney.
    Berdjis N; Hakenberg OW; Novotny V; Manseck A; Oehlschläger S; Wirth MP
    Scand J Urol Nephrol; 2007; 41(1):10-3. PubMed ID: 17366096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C; Song C; Hong JH; Kim CS; Ahn H
    J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
    Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
    J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microscopic venous invasion in renal cell carcinoma as a predictor of recurrence after radical surgery.
    Ishimura T; Sakai I; Hara I; Eto H; Miyake H
    Int J Urol; 2004 May; 11(5):264-8. PubMed ID: 15147540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant interleukin-2, interferon-alpha, and 5-fluorouracil immunochemotherapy after radical nephrectomy for locally advanced renal cell carcinoma.
    Hong SK; Kwak C; Lee SE
    Urology; 2005 Sep; 66(3):518-22. PubMed ID: 16140069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.